EP1310552A3 - Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren - Google Patents

Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren Download PDF

Info

Publication number: EP1310552A3
Authority: EP; European Patent Office
Prior art keywords: nucleic acids; related methods; polypeptides; posh nucleic; posh
Prior art date: 2001-11-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP02257796A

Other languages

English (en)

French (fr)

Other versions

EP1310552A2 (de

EP1310552B1 (de

Inventor

Iris Alroy

Shmuel Tuvia

Tsvika Greener

Danny Ben-Avraham

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Proteologics Inc

Original Assignee

Proteologics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-09

Filing date

2002-11-11

Publication date

2003-10-08

2002-11-11 Application filed by Proteologics Inc filed Critical Proteologics Inc

2003-05-14 Publication of EP1310552A2 publication Critical patent/EP1310552A2/de

2003-10-08 Publication of EP1310552A3 publication Critical patent/EP1310552A3/de

2003-11-10 Priority to AU2003304109A priority Critical patent/AU2003304109A1/en

2003-11-10 Priority to PCT/US2003/035712 priority patent/WO2004098492A2/en

2005-05-11 Priority to US11/127,559 priority patent/US20060287337A1/en

2007-06-13 Application granted granted Critical

2007-06-13 Publication of EP1310552B1 publication Critical patent/EP1310552B1/de

2022-11-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

102000039446 nucleic acids Human genes 0.000 title abstract 2
108020004707 nucleic acids Proteins 0.000 title abstract 2
150000007523 nucleic acids Chemical class 0.000 title abstract 2
229920001184 polypeptide Polymers 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
230000031018 biological processes and functions Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000017613 viral reproduction Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
- C12Y603/02019—Ubiquitin-protein ligase (6.3.2.19), i.e. ubiquitin-conjugating enzyme

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP02257796A 2001-11-09 2002-11-11 Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren Expired - Lifetime EP1310552B1 (de)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
AU2003304109A AU2003304109A1 (en)	2002-11-11	2003-11-10	Trans-golgi network-associated processes, methods and compositions related thereto
PCT/US2003/035712 WO2004098492A2 (en)	2002-11-11	2003-11-10	Trans-golgi network-associated processes, methods and compositions related thereto
US11/127,559 US20060287337A1 (en)	2001-11-09	2005-05-11	Trans-golgi network-associated processes, methods and compositions related thereto

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US34584601P	2001-11-09	2001-11-09
US345846P		2001-11-09
US36453002P	2002-03-15	2002-03-15
US364530P		2002-03-15

Publications (3)

Publication Number	Publication Date
EP1310552A2 EP1310552A2 (de)	2003-05-14
EP1310552A3 true EP1310552A3 (de)	2003-10-08
EP1310552B1 EP1310552B1 (de)	2007-06-13

Family

ID=26994569

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02257796A Expired - Lifetime EP1310552B1 (de)	2001-11-09	2002-11-11	Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren

Country Status (10)

Country	Link
US (4)	US7250250B2 (de)
EP (1)	EP1310552B1 (de)
JP (1)	JP2005519636A (de)
AT (1)	ATE364690T1 (de)
AU (1)	AU2002365160C1 (de)
CA (1)	CA2465973C (de)
DE (1)	DE60220621T2 (de)
IL (2)	IL161764A0 (de)
NZ (1)	NZ532908A (de)
WO (1)	WO2003095971A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106754883B (zh) *	2016-12-30	2019-10-29	中山大学	一种一步、无缝、非同源、多片段的基因拼接改造方法及其试剂盒

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE458485T1 (de)	2003-07-11	2010-03-15	Proteologics Inc	Ubiquitin-ligase-hemmer und verwandte verfahren
US20060188890A1 (en) *	2003-10-31	2006-08-24	Proteologics, Inc.	Ubiquitin-based protein interaction assays and related compositions
WO2006044747A2 (en) *	2004-10-15	2006-04-27	Signal Pharmaceuticals, Llc	P27 ubiquitination assay and methods of use
EP1820024B1 (de)	2004-12-01	2012-06-13	Proteologics, Ltd	Ubiquitin-ligase-assays und verwandte reagenzien
JP2008092911A (ja) *	2006-10-16	2008-04-24	Univ Of Tokyo	タンパク質結合検出方法
EP2196794A4 (de)	2007-08-30	2014-04-02	Mitsui Shipbuilding Eng	Fret-nachweisverfahren und -vorrichtung
US8691971B2 (en)	2008-09-23	2014-04-08	Scott G. Petersen	Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference
US9901617B2 (en) *	2013-08-14	2018-02-27	The Curators Of The University Of Missouri	Cell permeable inhibitors of the scaffold protein plenty of SH3 domains (POSH) or Sh3Rfl
WO2018085208A1 (en)	2016-11-02	2018-05-11	The Research Foundation For The State University Of New York	Methods of inhibiting viruses using compositions targeting tsg101-ubiquitin interaction
CN112764372A (zh) *	2020-12-25	2021-05-07	天津大学	基于vpx架构的多通道信号采集系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002053719A2 (en) *	2001-01-04	2002-07-11	Incyte Genomics, Inc.	Cytoskeleton-associated proteins
WO2002079449A2 (en) *	2001-03-28	2002-10-10	Incyte Genomics, Inc.	Molecules for disease detection and treatment

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000008181A2 (en) *	1998-08-07	2000-02-17	Onyx Pharmaceuticals, Inc.	Chp polypeptide, a ligand of pak65
CN1334875A (zh) *	1998-10-13	2002-02-06	昂尼克斯药物公司	新颖的细胞信号多肽和核酸
WO2000027865A1 (en)	1998-11-06	2000-05-18	The Brigham And Women's Hospital, Inc.	CHARACTERIZATION OF NOVEL GENE cbl-SL
WO2001088088A2 (en)	2000-05-18	2001-11-22	Hyseq, Inc.	Novel nucleic acids and polypeptides
WO2001064835A2 (en)	2000-02-28	2001-09-07	Hyseq, Inc.	Novel nucleic acids and polypeptides
EP1074617A3 (de)	1999-07-29	2004-04-21	Research Association for Biotechnology	Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU7701100A (en)	1999-09-03	2001-04-10	Millennium Pharmaceuticals, Inc.	Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
WO2001055301A2 (en)	2000-01-31	2001-08-02	Human Genome Sciences, Inc.	Nucleic acids, proteins, and antibodies
CA2399776A1 (en)	2000-02-03	2001-08-09	Hyseq, Inc.	Novel nucleic acids and polypeptides
WO2001060860A2 (en)	2000-02-17	2001-08-23	Millennium Predictive Medicine, Inc.	Genes differentially expressed in human prostate cancer and their use
WO2001070979A2 (en)	2000-03-21	2001-09-27	Millennium Pharmaceuticals, Inc.	Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
AU2001245945A1 (en)	2000-03-23	2001-10-03	Pe Corporation (Ny)	Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
AU2001247899A1 (en)	2000-04-06	2001-10-23	Genetics Institute, Llc	Polynucleotides encoding novel secreted proteins
EP1339872A2 (de)	2000-09-19	2003-09-03	Whitehead Institute For Biomedical Research	Genetische marker für tumore
EP1629082A4 (de)	2000-10-20	2009-07-22	Univ Massachusetts	Mit glucosetransport in zusammenhang stehende gene und deren verwendungen
EP1334113A4 (de)	2000-10-20	2007-08-08	Expression Diagnostics Inc	Erstellen von leukozytenexpressionsprofilen
AU2002241520A1 (en)	2000-11-28	2003-03-03	University Of Cincinnati	Blood assessment of injury
WO2002077235A2 (en)	2000-12-21	2002-10-03	Incyte Genomics, Inc.	Intracellular signaling molecules
JP2005503760A (ja)	2001-01-24	2005-02-10	プロテインデザインラブス，インコーポレイテッド	乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
US6743619B1 (en)	2001-01-30	2004-06-01	Nuvelo	Nucleic acids and polypeptides
JP2004536575A (ja)	2001-02-28	2004-12-09	コンドロジーン・インコーポレイテッド	変形性関節症に関連する組成物および方法
US20040236091A1 (en)	2001-03-28	2004-11-25	Chicz Roman M.	Translational profiling
WO2002085285A2 (en)	2001-04-18	2002-10-31	Wyeth	Methods and reagents for regulating bone and cartilage formation
CA2447357A1 (en)	2001-05-22	2002-11-28	Gene Logic, Inc.	Molecular toxicology modeling
WO2003022987A2 (en)	2001-07-26	2003-03-20	Eos Biotechnology, Inc.	Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
WO2003033646A2 (en)	2001-07-31	2003-04-24	Proteologics, Inc.	Compositions and methods for the modulation of viral maturation
AU2002330039A1 (en)	2001-09-17	2003-04-01	Eos Biotechnology, Inc.	Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
MXPA04003382A (es)	2001-10-31	2004-11-22	Pfizer Prod Inc	Agentes terapeuticos y diagnostico para transtornos de la eritropoyesis.
WO2003039490A2 (en)	2001-11-09	2003-05-15	Office Of Technology Licensing Stanford University	Compositions and methods for diagnosing and treating mental disorders
US20040096828A1 (en) *	2002-01-04	2004-05-20	Lu Dyung Aina M	Cytoskeleton-associated proteins

2002
- 2002-11-11 EP EP02257796A patent/EP1310552B1/de not_active Expired - Lifetime
- 2002-11-11 AT AT02257796T patent/ATE364690T1/de not_active IP Right Cessation
- 2002-11-11 DE DE60220621T patent/DE60220621T2/de not_active Expired - Lifetime
- 2002-11-12 JP JP2004503917A patent/JP2005519636A/ja active Pending
- 2002-11-12 CA CA2465973A patent/CA2465973C/en not_active Expired - Fee Related
- 2002-11-12 US US10/293,965 patent/US7250250B2/en not_active Expired - Fee Related
- 2002-11-12 NZ NZ532908A patent/NZ532908A/en not_active IP Right Cessation
- 2002-11-12 AU AU2002365160A patent/AU2002365160C1/en not_active Ceased
- 2002-11-12 WO PCT/US2002/036366 patent/WO2003095971A2/en not_active Ceased
- 2002-11-12 IL IL16176402A patent/IL161764A0/xx unknown
2004
- 2004-05-04 IL IL161764A patent/IL161764A/en not_active IP Right Cessation
2005
- 2005-01-06 US US11/031,482 patent/US7429643B2/en not_active Expired - Fee Related
- 2005-01-07 US US11/031,737 patent/US7268227B2/en not_active Expired - Fee Related
2007
- 2007-07-30 US US11/881,958 patent/US20080187538A1/en not_active Abandoned

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002053719A2 (en) *	2001-01-04	2002-07-11	Incyte Genomics, Inc.	Cytoskeleton-associated proteins
WO2002079449A2 (en) *	2001-03-28	2002-10-10	Incyte Genomics, Inc.	Molecules for disease detection and treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENSEQ [online] 12 February 2003 (2003-02-12), DAFFO,A. ET AL.: "Human MDDT polypeptide SEQ ID NO 542", XP002250464, Database accession no. ABU11595 *
TAPON NICOLAS ET AL: "A new Rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 17, no. 5, 2 March 1998 (1998-03-02), pages 1395 - 1404, XP002250463, ISSN: 0261-4189 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106754883B (zh) *	2016-12-30	2019-10-29	中山大学	一种一步、无缝、非同源、多片段的基因拼接改造方法及其试剂盒

Also Published As

Publication number	Publication date
AU2002365160A1 (en)	2003-11-11
IL161764A (en)	2010-12-30
WO2003095971A3 (en)	2005-04-28
CA2465973A1 (en)	2003-11-20
US7250250B2 (en)	2007-07-31
EP1310552A2 (de)	2003-05-14
JP2005519636A (ja)	2005-07-07
WO2003095971A2 (en)	2003-11-20
CA2465973C (en)	2013-04-16
AU2002365160B2 (en)	2008-10-30
US7429643B2 (en)	2008-09-30
AU2002365160C1 (en)	2009-08-13
NZ532908A (en)	2008-04-30
HK1055996A1 (en)	2004-01-30
US20040025196A1 (en)	2004-02-05
US7268227B2 (en)	2007-09-11
ATE364690T1 (de)	2007-07-15
US20080187538A1 (en)	2008-08-07
DE60220621D1 (de)	2007-07-26
EP1310552B1 (de)	2007-06-13
IL161764A0 (en)	2005-11-20
DE60220621T2 (de)	2008-03-06
US20060035213A1 (en)	2006-02-16
US20060019240A1 (en)	2006-01-26

Legal Events

Date	Code	Title	Description
2003-03-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-05-14	AK	Designated contracting states	Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2003-05-14	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2003-08-13	RIN1	Information on inventor provided before grant (corrected)	Inventor name: BEN-AVRAHAM, DANNY Inventor name: ALROY, IRIS Inventor name: TUVIA, SHMUEL Inventor name: GREENER, TSVIKA
2003-08-22	PUAL	Search report despatched	Free format text: ORIGINAL CODE: 0009013
2003-10-08	AK	Designated contracting states	Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2003-10-08	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2004-05-19	17P	Request for examination filed	Effective date: 20040323
2004-06-30	AKX	Designation fees paid	Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2004-07-07	17Q	First examination report despatched	Effective date: 20040521
2006-11-11	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2007-03-29	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2007-05-11	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2007-06-13	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2007-06-13	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2007-06-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2007-07-11	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2007-07-26	REF	Corresponds to:	Ref document number: 60220621 Country of ref document: DE Date of ref document: 20070726 Kind code of ref document: P
2007-09-13	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070913
2007-11-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: NV Representative=s name: VOSSIUS & PARTNER
2007-11-24	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2007-11-30	ET	Fr: translation filed
2007-12-03	NLV1	Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
2007-12-28	REG	Reference to a national code	Ref country code: HK Ref legal event code: GR Ref document number: 1055996 Country of ref document: HK
2008-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070924 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071113 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070913 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2008-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PCAR Free format text: VOSSIUS & PARTNER;NADELBERG 3;4051 BASEL (CH)
2008-02-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2008-04-18	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2008-04-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2008-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070914 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2008-05-21	26N	No opposition filed	Effective date: 20080314
2008-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071130
2009-01-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2009-02-27	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2009-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2009-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071111
2009-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070613
2010-10-13	REG	Reference to a national code	Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20100916 AND 20100922
2010-11-12	REG	Reference to a national code	Ref country code: FR Ref legal event code: TP
2011-01-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PUE Owner name: PROTEOLOGICS, LTD. Free format text: PROTEOLOGICS, INC.#40 RAMLAND ROAD SOUTH#ORANGEBURG, NY 10962-2617 (US) -TRANSFER TO- PROTEOLOGICS, LTD.#2 HOLZMAN STREET WEIZMANN SCIENCE PARK#REHOVOT, ISRAEL 76124 (IL)
2014-01-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: CH Payment date: 20131121 Year of fee payment: 12 Ref country code: FR Payment date: 20131120 Year of fee payment: 12 Ref country code: DE Payment date: 20131121 Year of fee payment: 12 Ref country code: GB Payment date: 20131120 Year of fee payment: 12 Ref country code: IE Payment date: 20131126 Year of fee payment: 12
2014-02-28	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: BE Payment date: 20131121 Year of fee payment: 12
2015-06-02	REG	Reference to a national code	Ref country code: DE Ref legal event code: R119 Ref document number: 60220621 Country of ref document: DE
2015-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141130
2015-06-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2015-07-29	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20141111
2015-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141130
2015-08-26	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2015-08-28	REG	Reference to a national code	Ref country code: FR Ref legal event code: ST Effective date: 20150731
2015-10-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141111 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141111 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150602
2015-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141201

Publication	Publication Date	Title
AU1593001A (en)	2001-06-06	Recombinant gelatin in vaccines
AU2002366951A1 (en)	2003-07-09	Novel nucleic acids and polypeptides
AU2002326877A1 (en)	2003-03-24	Novel nucleic acids and polypeptides
AU2002314709A1 (en)	2002-10-21	Novel nucleic acids and polypeptides
AU2002343417A1 (en)	2003-04-14	Novel nucleic acids and polypeptides
EP1310552A3 (de)	2003-10-08	Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren
AU2001244609A1 (en)	2001-10-15	Novel protein, dna thereof and process for producing the same
AU2002233543A1 (en)	2002-09-12	Novel p53-inducible protein
AU2002336658A1 (en)	2003-05-12	Il-4 mutein proteins, antibodies, compositions, methods and uses
AU2003262789A1 (en)	2004-03-11	Abca13 nucleic acids and proteins, and uses thereof
AU2002365269A1 (en)	2003-07-24	Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2002331847A1 (en)	2003-04-01	Composition for stabilizing biological materials
WO2005001485A3 (en)	2005-08-25	Pem-3-like compositions and related methods thereof
AU2002221164A1 (en)	2003-06-10	(r)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same
AU2002250254A1 (en)	2002-09-24	Nucleic acids, proteins, and antibodies
WO2003078601A3 (en)	2004-09-23	Posh nucleic acids, polypeptides and related methods
AU2002365925A1 (en)	2003-09-02	Rsv proteins, antibodies, compositions, methods and uses
AU2002316348A1 (en)	2003-01-08	Chimeric capsid proteins and uses thereof
AU2002323612A1 (en)	2003-03-18	Novel clark protein and nucleic acid molecules and uses therefor
AU2002357609A1 (en)	2003-07-09	Novel proteins and dnas thereof
WO2002102992A8 (en)	2004-07-22	Novel nucleic acids, polypeptides, methods of making, and uses thereof
WO2002079390A9 (en)	2013-10-24	$i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
HK1065817A (zh)	2005-03-04	核心糖基化hcv包膜蛋白
HK1064299A (en)	2005-01-28	Biological response modifier composition and uses thereof
AU2002344879A1 (en)	2003-01-02	Biological response modifier composition and uses thereof

EP1310552A3 - Posh Nukleinsäure, Polypeptide und darauf bezogene Verfahren - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (3)

Applications Claiming Priority (4)

Publications (3)

Family

ID=26994569

Family Applications (1)

Country Status (10)

Cited By (1)

Families Citing this family (10)

Citations (2)

Family Cites Families (30)

Patent Citations (2)

Non-Patent Citations (2)

Cited By (1)

Also Published As

Similar Documents

Legal Events